Physician profile
Roy Khoury
NPI 1316114812
$2,048.09
in general payments reported to CMS, 2019-2025
26 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $200 · 2021: $350 · 2022: $351 · 2023: $286 · 2024: $232 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.17 | 2019-2023 | |
| Daiichi Sankyo INC. | $290.26 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $128.60 | 2023-2025 | Veozah |
| Meditrina | $120.41 | 2022-2024 | |
| Myovant Sciences INC. | $113.33 | 2021-2022 | |
| Medtronic, INC. | $94.50 | 2024 | Sonicision |
| Pfizer INC. | $77.76 | 2022-2024 | |
| Renovia INC | $73.26 | 2019 | |
| Avion Pharmaceuticals | $71.21 | 2019-2022 | |
| Coopersurgical, INC. | $67.81 | 2021-2023 | Summit Doppler |
| Ethicon US, LLC | $66.13 | 2025 | Stratafix, Ethicon, Vistaseal |
| Therapeuticsmd, INC. | $64.40 | 2020-2021 | |
| Mission Pharmacal Company | $64.29 | 2019 | |
| Sumitomo Pharma America, INC. | $57.09 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $42.17 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $36.36 | 2021-2025 | Novasure, Myosure Tissue Removal Device |
| Aspira Women'S Health INC | $36.31 | 2019-2023 | Ova1 |
| Merck Sharp & Dohme LLC | $33.69 | 2021-2023 | Lynparza, Keytruda |
| Shield Therapeutics INC | $25.43 | 2025 | |
| Optumhealth Care Solutions, LLC | $23.00 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Minerva Surgical, INC | $21.74 | 2020 | |
| Gilead Sciences, INC. | $20.42 | 2025 | |
| Organon LLC | $19.99 | 2024 | |
| Ferring Pharmaceuticals INC. | $16.21 | 2019 | |
| Millicent US INC | $14.78 | 2019 | |
| Duchesnay USA Incorporated | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Khoury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.